ImmPort

ImmPort is a Web portal that contains data from NIAID-funded immunology studies, including basic research and clinical trials. The portal provides online tools that allow users to analyze the data and visualize the results. ImmPort enables the integration of data from a variety of laboratories and supports collaboration between scientists, helping to generate novel hypotheses and potential new discoveries.

More information about this resource is available at ImmPort: Bioinformatics for the Future of Immunology

Main Areas of Focus

  • To provide an open access platform for research data sharing.
  • To create an integrated environment that broadens the usefulness of scientific data and advances hypothesis-driven and hypothesis-generating research.
  • To accelerate scientific discovery while extending the value of scientific data in all areas of immunological research.
  • To promote rapid availability of important findings, making new discoveries available to the research community for further analysis and interpretation.
  • To provide analysis tools to advance research in basic and clinical immunology.

Support Services

  • Advanced information technology support in the archiving and exchange of scientific data for the diverse community of life science researchers supported by NIAID/DAIT, including analysis workflow and automated clustering.
  • Serves as a long-term, sustainable archive of research and clinical data. 

Tools

  • Extensive data warehouse containing experimental data and metadata describing the purpose of the study and the methods of data generation
  • Data analysis tools
  • Gene lists

Standards

  • HLA Documentation and Analysis Methods 

Collaboration Opportunities

  • Research data sharing
  • Data visualization and analysis tools for public, pre-release, and private data

Who Can Use This Resource

  • Access to ImmPort research and clinical data is available to any researcher in the life sciences community after a brief registration and approval process

How To Get Started

Access to ImmPort research and clinical data is available to any researcher in the life sciences community after a brief registration and approval process. Users will be asked to accept a data sharing and access agreement before access to the ImmPort system is granted. If users choose to submit their own data, either for eventual sharing or for use of analysis tools, the data will be kept in a confidential private workspace until they choose to share.

Contact Information

Dr. Quan Chen

Content last reviewed on